Evaluation of treatment adherence in patients with type 2 diabetes
Abstract: DM type 2 is a noncommunicable disease of considerable relevance worldwide. It is feasible to control its long term effects with medication and a healthy lifestyle. A key factor in the prevention of complications is treatment adherence. Although it is known to be multifactor...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | Artículo revista |
Publicado: |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2021
|
Materias: | |
Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/34866 |
Aporte de: |
id |
I10-R10-article-34866 |
---|---|
record_format |
ojs |
institution |
Universidad Nacional de Córdoba |
institution_str |
I-10 |
repository_str |
R-10 |
container_title_str |
Revistas de la UNC |
format |
Artículo revista |
topic |
type 2 diabetes medication adherence treatment adherence Diabetes Mellitus Tipo 2 cumplimiento de la medicación adherencia al tratamiento . |
spellingShingle |
type 2 diabetes medication adherence treatment adherence Diabetes Mellitus Tipo 2 cumplimiento de la medicación adherencia al tratamiento . Angeli , C Beltramo , FL Bertona, B Levit , BA Linares , S Garcia Redondo , AP Igarzabal , P Yorio, M Evaluation of treatment adherence in patients with type 2 diabetes |
topic_facet |
type 2 diabetes medication adherence treatment adherence Diabetes Mellitus Tipo 2 cumplimiento de la medicación adherencia al tratamiento . |
author |
Angeli , C Beltramo , FL Bertona, B Levit , BA Linares , S Garcia Redondo , AP Igarzabal , P Yorio, M |
author_facet |
Angeli , C Beltramo , FL Bertona, B Levit , BA Linares , S Garcia Redondo , AP Igarzabal , P Yorio, M |
author_sort |
Angeli , C |
title |
Evaluation of treatment adherence in patients with type 2 diabetes |
title_short |
Evaluation of treatment adherence in patients with type 2 diabetes |
title_full |
Evaluation of treatment adherence in patients with type 2 diabetes |
title_fullStr |
Evaluation of treatment adherence in patients with type 2 diabetes |
title_full_unstemmed |
Evaluation of treatment adherence in patients with type 2 diabetes |
title_sort |
evaluation of treatment adherence in patients with type 2 diabetes |
description |
Abstract:
DM type 2 is a noncommunicable disease of considerable relevance worldwide. It is feasible to control its long term effects with medication and a healthy lifestyle. A key factor in the prevention of complications is treatment adherence. Although it is known to be multifactorial, its relation with the patient’s level of knowledge about their disease has been proposed.
The objective of this study is to determine treatment adherence in patients with type 2 diabetes who attend Hospital Cordoba within the context of the ProCorDia program, and its relationship with their knowledge of the disease. In addition, we intend to analyze this data aking into account demographic variables.
A retrospective, observational, transversal study was carried out. It took place in the Service of Diabetes of Hospital Cordoba, in september 2019. In a convenience sample of 106 patients, over 18 years old, demographic data was obtained and validated tools were applied to evaluate treatment adherence (adherent / non-adherent; Morisky-Green Test) and disease knowledge (knower/ non-knower; Batalla Test). The statistical analysis was made with the Chi-square test.
The age range was 29 - 76, with an average age standing at 56. 64% resulted as “non-adherent”. 30% was “non-knower”. No significant association was found between treatment adherence and disease knowledge. No significant association was evidenced between disease knowledge and educational attainment. No gender differences were perceived. Treatment adherence tends to be associated with age range (p=0,0594), with lower adherence in the group of 29-45 years old.
Treatment adherence and disease knowledge are not associated in patients with diabetes. Patients in this study showed low rates of adherence even though they knew about their disease, which is relevant because it was made in the third level of attention care, within a monitoring program (ProCorDia). New studies are required to develop effective strategies of intervention.
|
publisher |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología |
publishDate |
2021 |
url |
https://revistas.unc.edu.ar/index.php/med/article/view/34866 |
work_keys_str_mv |
AT angelic evaluationoftreatmentadherenceinpatientswithtype2diabetes AT beltramofl evaluationoftreatmentadherenceinpatientswithtype2diabetes AT bertonab evaluationoftreatmentadherenceinpatientswithtype2diabetes AT levitba evaluationoftreatmentadherenceinpatientswithtype2diabetes AT linaress evaluationoftreatmentadherenceinpatientswithtype2diabetes AT garciaredondoap evaluationoftreatmentadherenceinpatientswithtype2diabetes AT igarzabalp evaluationoftreatmentadherenceinpatientswithtype2diabetes AT yoriom evaluationoftreatmentadherenceinpatientswithtype2diabetes AT angelic evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT beltramofl evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT bertonab evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT levitba evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT linaress evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT garciaredondoap evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT igarzabalp evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT yoriom evaluaciondelaadherenciafarmacoterapeuticaenpacientescondiabetestipo2 AT angelic a AT beltramofl a AT bertonab a AT levitba a AT linaress a AT garciaredondoap a AT igarzabalp a AT yoriom a |
first_indexed |
2022-10-04T12:56:16Z |
last_indexed |
2022-10-04T12:56:16Z |
_version_ |
1770719113812901888 |
spelling |
I10-R10-article-348662022-06-07T14:43:30Z Evaluation of treatment adherence in patients with type 2 diabetes Evaluación de la adherencia farmacoterapéutica en pacientes con diabetes tipo 2 A Angeli , C Beltramo , FL Bertona, B Levit , BA Linares , S Garcia Redondo , AP Igarzabal , P Yorio, M type 2 diabetes medication adherence treatment adherence Diabetes Mellitus Tipo 2 cumplimiento de la medicación adherencia al tratamiento . Abstract: DM type 2 is a noncommunicable disease of considerable relevance worldwide. It is feasible to control its long term effects with medication and a healthy lifestyle. A key factor in the prevention of complications is treatment adherence. Although it is known to be multifactorial, its relation with the patient’s level of knowledge about their disease has been proposed. The objective of this study is to determine treatment adherence in patients with type 2 diabetes who attend Hospital Cordoba within the context of the ProCorDia program, and its relationship with their knowledge of the disease. In addition, we intend to analyze this data aking into account demographic variables. A retrospective, observational, transversal study was carried out. It took place in the Service of Diabetes of Hospital Cordoba, in september 2019. In a convenience sample of 106 patients, over 18 years old, demographic data was obtained and validated tools were applied to evaluate treatment adherence (adherent / non-adherent; Morisky-Green Test) and disease knowledge (knower/ non-knower; Batalla Test). The statistical analysis was made with the Chi-square test. The age range was 29 - 76, with an average age standing at 56. 64% resulted as “non-adherent”. 30% was “non-knower”. No significant association was found between treatment adherence and disease knowledge. No significant association was evidenced between disease knowledge and educational attainment. No gender differences were perceived. Treatment adherence tends to be associated with age range (p=0,0594), with lower adherence in the group of 29-45 years old. Treatment adherence and disease knowledge are not associated in patients with diabetes. Patients in this study showed low rates of adherence even though they knew about their disease, which is relevant because it was made in the third level of attention care, within a monitoring program (ProCorDia). New studies are required to develop effective strategies of intervention. Resumen: La diabetes tipo 2 es una enfermedad crónica no transmisible de gran relevancia a nivel mundial. Sus efectos a largo plazo son factibles de ser controlados mediante medicación y un hábito de vida saludable. La adherencia al tratamiento es un factor clave en la prevención de sus complicaciones. Si bien es un proceso multifactorial, se ha propuesto su relación con el nivel de conocimiento del paciente sobre su enfermedad. El objetivo de este trabajo es conocer la adherencia al tratamiento en pacientes con diabetes tipo 2 que asisten al Hospital Córdoba en contexto del programa ProCorDia y su relación con el nivel de conocimiento sobre la enfermedad. Adicionalmente, analizarlos en función de variables demográficas. Se realizó un estudio retrospectivo, observacional, de corte transversal, realizado en el Servicio de Diabetes del Hospital Córdoba, durante el mes de septiembre de 2019. En una muestra por conveniencia de 106 pacientes, mayores de 18 años, se recabaron datos demográficos y se aplicaron herramientas validadas para evaluar la adherencia al tratamiento (adherente/no adherente; Test de Morisky-Green) y el conocimiento de la enfermedad (conocedor/no conocedor; Test de Batalla). Para el análisis estadístico se realizaron pruebas Chi-cuadrado. El rango etario fue entre 29 y 76 años, con una media de edad de 56 años. El 64% resultó “no adherente” al tratamiento. El 30% fue “no conocedor” sobre su enfermedad. No se encontró asociación significativa entre ambas variables. Tampoco se evidenció asociación entre el grado de conocimiento y el nivel educativo de los encuestados. No se percibieron diferencias en cuanto al sexo. La adherencia al tratamiento tiende a asociarse con el grupo etario (p=0,0594), con adherencia menor en el grupo de 29 a 45 años. No se asocia significativamente la adherencia al tratamiento y el nivel de conocimiento sobre la enfermedad en pacientes con diabetes. Los pacientes encuestados mostraron bajos niveles de adherencia a pesar de conocer sobre su enfermedad, hecho relevante por tratarse de un hospital del tercer nivel de atención, dentro de un programa de seguimiento (ProCorDia). Son necesarios nuevos estudios para guiar estrategias de intervención eficaces. . Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2021-10-12 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion texto texto texto https://revistas.unc.edu.ar/index.php/med/article/view/34866 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 78 No. Suplemento (2021): Suplemento JIC XXII Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 78 Núm. Suplemento (2021): Suplemento JIC XXII Revista da Faculdade de Ciências Médicas de Córdoba; v. 78 n. Suplemento (2021): Suplemento JIC XXII 1853-0605 0014-6722 http://creativecommons.org/licenses/by-nc/4.0 |